Bio News

A new photothermal nanoparticle developed by Chinese researchers reached 63.8°C after 5 minutes of irradiation with an 808-nm laser and was found to kill more than 92% of osteosarcoma cells. The IEICO-F nanoparticles, based on an acceptor-donor-acceptor (A-D-A) structure, increased photothermal conversion efficiency to 65.59% and functioned at the low power density of 0.33 W/cm², the medical safety standard. In animal model experiments, the nanoparticles completely eliminated solid tumors, suggesting potential future applications in the treatment of other tumors.

BIOBOOK TEAM
biobookmedia@biobook.co.krCG Oncology: Cretostimogene Cuts Bladder Cancer Recurrence Risk by 68%; FDA Filing to Expand
CG Oncology: 68% Lower Risk of Bladder Cancer Recurrence; Shares Surge 12%
U.S. FDA Rejects Summit and Akeso’s PD-1/VEGF Lung Cancer Drug
Biogen Signs $411 Million Deal With Trimtech for Neurodegenerative Diseases
AstraZeneca’s new myasthenia gravis drug cligepa approved in the U.S. and EU
Helus meets primary endpoint in phase 3 trial of depression drug candidate, with 7.6-point improvement over placebo